Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor

NCT03518138 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Vasomotor Symptoms (VMS)

Interventions

DRUG: Q-122
DRUG: Placebo

Sponsor

Que Oncology

Collaborators

[object Object]